HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.

Abstract
Subunit vaccines have been investigated in over 1000 clinical trials of cancer immunotherapy, but have shown limited efficacy. Nanovaccines may improve efficacy but have rarely been clinically translated. By conjugating molecular vaccines with Evans blue (EB) into albumin-binding vaccines (AlbiVax), here we develop clinically promising albumin/AlbiVax nanocomplexes that self-assemble in vivo from AlbiVax and endogenous albumin for efficient vaccine delivery and potent cancer immunotherapy. PET pharmacoimaging, super-resolution microscopies, and flow cytometry reveal almost 100-fold more efficient co-delivery of CpG and antigens (Ags) to lymph nodes (LNs) by albumin/AlbiVax than benchmark incomplete Freund's adjuvant (IFA). Albumin/AlbiVax elicits ~10 times more frequent peripheral antigen-specific CD8+ cytotoxic T lymphocytes with immune memory than IFA-emulsifying vaccines. Albumin/AlbiVax specifically inhibits progression of established primary or metastatic EG7.OVA, B16F10, and MC38 tumors; combination with anti-PD-1 and/or Abraxane further potentiates immunotherapy and eradicates most MC38 tumors. Albumin/AlbiVax nanocomplexes are thus a robust platform for combination cancer immunotherapy.
AuthorsGuizhi Zhu, Geoffrey M Lynn, Orit Jacobson, Kai Chen, Yi Liu, Huimin Zhang, Ying Ma, Fuwu Zhang, Rui Tian, Qianqian Ni, Siyuan Cheng, Zhantong Wang, Nan Lu, Bryant C Yung, Zhe Wang, Lixin Lang, Xiao Fu, Albert Jin, Ido D Weiss, Harshad Vishwasrao, Gang Niu, Hari Shroff, Dennis M Klinman, Robert A Seder, Xiaoyuan Chen
JournalNature communications (Nat Commun) Vol. 8 Issue 1 Pg. 1954 (12 05 2017) ISSN: 2041-1723 [Electronic] England
PMID29203865 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Albumin-Bound Paclitaxel
  • Albumins
  • Antigens, Neoplasm
  • Antineoplastic Agents
  • Antineoplastic Agents, Immunological
  • Cancer Vaccines
  • Lipids
  • incomplete Freund's adjuvant
  • Freund's Adjuvant
Topics
  • Adjuvants, Immunologic (pharmacology)
  • Albumin-Bound Paclitaxel (pharmacology)
  • Albumins
  • Animals
  • Antigens, Neoplasm (immunology)
  • Antineoplastic Agents (pharmacology)
  • Antineoplastic Agents, Immunological (pharmacology)
  • Cancer Vaccines (administration & dosage, immunology, pharmacology)
  • Cell Line, Tumor
  • Drug Delivery Systems
  • Freund's Adjuvant (pharmacology)
  • Immunotherapy
  • Lipids (pharmacology)
  • Lymph Nodes (drug effects, pathology)
  • Melanoma, Experimental (pathology)
  • Mice
  • Molecular Docking Simulation
  • Nanostructures
  • Positron-Emission Tomography
  • T-Lymphocytes, Cytotoxic (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: